AngioDynamics Accounts Payable from 2010 to 2024
| ANGO Stock | USD 6.03 0.23 3.67% |
Accounts Payable | First Reported 2002-05-31 | Previous Quarter 37.6 M | Current Value 35.2 M | Quarterly Volatility 10.5 M |
Check AngioDynamics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AngioDynamics main balance sheet or income statement drivers, such as Depreciation And Amortization of 17.8 M, Interest Expense of 1.7 M or Total Revenue of 242.9 M, as well as many exotic indicators such as Price To Sales Ratio of 1.2, Dividend Yield of 0.0 or PTB Ratio of 0.93. AngioDynamics financial statements analysis is a perfect complement when working with AngioDynamics Valuation or Volatility modules.
AngioDynamics | Accounts Payable |
Latest AngioDynamics' Accounts Payable Growth Pattern
Below is the plot of the Accounts Payable of AngioDynamics over the last few years. An accounting item on the balance sheet that represents AngioDynamics obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of AngioDynamics are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. AngioDynamics' Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AngioDynamics' overall financial position and show how it may be relating to other accounts over time.
| Accounts Payable | 10 Years Trend |
|
Accounts Payable |
| Timeline |
AngioDynamics Accounts Payable Regression Statistics
| Arithmetic Mean | 25,830,206 | |
| Geometric Mean | 21,874,744 | |
| Coefficient Of Variation | 48.04 | |
| Mean Deviation | 9,460,647 | |
| Median | 23,668,000 | |
| Standard Deviation | 12,407,834 | |
| Sample Variance | 154T | |
| Range | 46.5M | |
| R-Value | 0.63 | |
| Mean Square Error | 100T | |
| R-Squared | 0.40 | |
| Significance | 0.01 | |
| Slope | 1,748,160 | |
| Total Sum of Squares | 2155.4T |
AngioDynamics Accounts Payable History
About AngioDynamics Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include AngioDynamics income statement, its balance sheet, and the statement of cash flows. AngioDynamics investors use historical funamental indicators, such as AngioDynamics's Accounts Payable, to determine how well the company is positioned to perform in the future. Although AngioDynamics investors may use each financial statement separately, they are all related. The changes in AngioDynamics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on AngioDynamics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on AngioDynamics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in AngioDynamics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Accounts Payable | 46.5 M | 48.8 M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards AngioDynamics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, AngioDynamics' short interest history, or implied volatility extrapolated from AngioDynamics options trading.
Pair Trading with AngioDynamics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AngioDynamics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AngioDynamics will appreciate offsetting losses from the drop in the long position's value.Moving together with AngioDynamics Stock
| 0.66 | NXL | Nexalin Technology | PairCorr |
Moving against AngioDynamics Stock
| 0.72 | EFTR | Effector Therapeutics Financial Report 14th of May 2024 | PairCorr |
| 0.68 | BJDX | Bluejay Diagnostics Financial Report 8th of May 2024 | PairCorr |
| 0.63 | EVH | Evolent Health Financial Report 1st of May 2024 | PairCorr |
| 0.63 | NRC | National Research Corp | PairCorr |
| 0.55 | TIVC | Tivic Health Systems | PairCorr |
The ability to find closely correlated positions to AngioDynamics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AngioDynamics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AngioDynamics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AngioDynamics to buy it.
The correlation of AngioDynamics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AngioDynamics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AngioDynamics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AngioDynamics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of AngioDynamics Correlation against competitors. To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.Note that the AngioDynamics information on this page should be used as a complementary analysis to other AngioDynamics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Complementary Tools for AngioDynamics Stock analysis
When running AngioDynamics' price analysis, check to measure AngioDynamics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AngioDynamics is operating at the current time. Most of AngioDynamics' value examination focuses on studying past and present price action to predict the probability of AngioDynamics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AngioDynamics' price. Additionally, you may evaluate how the addition of AngioDynamics to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |
Is AngioDynamics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AngioDynamics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.80) | Revenue Per Share 8.105 | Quarterly Revenue Growth (0.07) | Return On Assets (0.05) | Return On Equity (0.62) |
The market value of AngioDynamics is measured differently than its book value, which is the value of AngioDynamics that is recorded on the company's balance sheet. Investors also form their own opinion of AngioDynamics' value that differs from its market value or its book value, called intrinsic value, which is AngioDynamics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AngioDynamics' market value can be influenced by many factors that don't directly affect AngioDynamics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AngioDynamics' value and its price as these two are different measures arrived at by different means. Investors typically determine if AngioDynamics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AngioDynamics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.